Wednesday 6-25-2014 Achillion Pharmaceuticals (ACH
Post# of 94
Posted On: 06/25/2014 8:23:47 PM
Wednesday 6-25-2014 Achillion Pharmaceuticals (ACHN) $ACHN opened at 7.58 hitting the high price of 7.64 and a day low of 7.26 with a total volume of 4,696,053. ACHN had a previous close of 7.59 and has been seeing an average volume of 15,294,885.
Overall Average: 80% Buy
Recent stock forum discussions about ACHN http://investorshangout.com/search?q=ACHN&...mp;yt0=Go!
Achillion
at Investor's Business Daily - Fri Jun 20, 5:38PM CDT
Achillion (ACHN) shares rose 0.6% to 8.13 after R. W. Baird noted that Merck's (MRK) official tender offer indicated that there was another bidder for Idenix Pharmaceuticals, which means that a company is still looking for a nucleoside hepatitis C... (full story)
Achillion Could Win Idenix's Mystery Suitor: Analyst
at Investor's Business Daily - Fri Jun 20, 11:44AM CDT
Hot biotech stock Achillion Pharmaceuticals (ACHN) was up 2%, near 8.20, in midday trading in the stock market today after an analyst found more support for its prospects as a buyout candidate. R. W. Baird's Brian Skorney noted that Merck's (MRK)... (full story)
The Zacks Analyst Blog Highlights: Idenix, Achillion Pharmaceuticals, Nektar, Orexigen, Celgene, Alexion and Biogen
PR Newswire - Thu Jun 19, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Idenix (Nasdaq:IDIX-Free Report), Achillion Pharmaceuticals (Nasdaq:ACHN-Free Report), Nektar (Nasdaq:NKTR-Free Report), Orexigen (Nasdaq:OREX-Free Report), Celgene (Nasdaq:CELG-Free Report), Alexion (Nasdaq:ALXN-Free Report) and Biogen (Nasdaq:BIIB-Free Report). (full story)
Biotech Stock Roundup: HCV Back in Focus - Idenix, Achillion Soar - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Jun 18, 9:33AM CDT
It was about hepatitis C cirus (HCV) treatments and companies last week with the Merck-Idenix acquisition announcement grabbing eyeballs. (full story)
Nasdaq stocks posting largest volume increases
AP - Tue Jun 17, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading: (full story)
Nasdaq stocks posting largest percentage increases
AP - Tue Jun 17, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading: (full story)
Most active Nasdaq-traded stocks
AP - Tue Jun 17, 5:03PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading: (full story)
Critical Alerts For Bank of America, Achillion Pharmaceuticals, Walmart, SunEdison, and Advanced Micro Devices Released By InvestorsObserver
PR Newswire - Tue Jun 17, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for BAC, ACHN, WMT, SUNE, and AMD. (full story)
Achillion Gets Massive Price Target Hike On HCV Drugs
at Investor's Business Daily - Mon Jun 16, 10:18PM CDT
Biotech Achillion Pharmaceuticals (ACHN) got another boost Monday when Maxim Group more than tripled its price target on the stock, sending shares up 21% on the stock market today. After having dinner with company executives, analyst Jason Kolbert... (full story)
Achillion gets price target hike
at Investor's Business Daily - Mon Jun 16, 5:56PM CDT
The biotech company's shares soared 20.9% to 7.82 after Maxim Group more than tripled its price target on Achillion Pharmaceuticals (ACHN) stock. Analyst Jason Kolbert increased his target to 22 from 6 on the potential of hepatitis C drug candidates,... (full story)
Why Fusion-io, Achillion Pharmaceuticals, and Covidien Are Today's 3 Best Stocks
Sean Williams, The Motley Fool - Motley Fool - Mon Jun 16, 4:15PM CDT
Following the first down week for the broad-based S&P 500 in quite some time investors were looking for something positive to start their work week, and a bevy of economic data gave them what they were looking for. Industrial production... (full story)
Why Achillion Pharmaceuticals (ACHN) Is Spiking Today
at The Street - Mon Jun 16, 9:33AM CDT
Achillion Pharmaceuticals (ACHN) is rocketing up after having its price target raised significantly to $22 from $6 by analysts at Maxim. (full story)
3 Stocks That Soared Stupendously This Week
Keith Speights, The Motley Fool - Motley Fool - Sun Jun 15, 8:15AM CDT
How would you like a 40% gain in one week? How about gains of over 120% -- or more than 220%? Shareholders of three health-care stocks don't have to wonder how they'd like those types of returns. They experienced the joy first-hand. One of this... (full story)
This Week in Biotech: Actions Speak Louder Than Words
Sean Williams, The Motley Fool - Motley Fool - Sat Jun 14, 10:20AM CDT
With the SPDR S&P Biotech Index up 39% over the trailing 12-month period , it's evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let's have a look at some of the rulings, studies, and... (full story)
Today's Top Biotech Stocks to Watch: Achillion Pharmaceuticals, Nektar Therapeutics and Progenics Ph
George Budwell, The Motley Fool - Motley Fool - Fri Jun 13, 8:02AM CDT
Let's take a look at today's top stories in biotech and health care. Keep an eye out for Achillion Pharmaceuticals , Nektar Therapeutics and Progenics Pharmaceuticals . Achillion falling back down to Earth Shares of hepatitis C... (full story)
Overall Average: 80% Buy
Recent stock forum discussions about ACHN http://investorshangout.com/search?q=ACHN&...mp;yt0=Go!
Achillion
at Investor's Business Daily - Fri Jun 20, 5:38PM CDT
Achillion (ACHN) shares rose 0.6% to 8.13 after R. W. Baird noted that Merck's (MRK) official tender offer indicated that there was another bidder for Idenix Pharmaceuticals, which means that a company is still looking for a nucleoside hepatitis C... (full story)
Achillion Could Win Idenix's Mystery Suitor: Analyst
at Investor's Business Daily - Fri Jun 20, 11:44AM CDT
Hot biotech stock Achillion Pharmaceuticals (ACHN) was up 2%, near 8.20, in midday trading in the stock market today after an analyst found more support for its prospects as a buyout candidate. R. W. Baird's Brian Skorney noted that Merck's (MRK)... (full story)
The Zacks Analyst Blog Highlights: Idenix, Achillion Pharmaceuticals, Nektar, Orexigen, Celgene, Alexion and Biogen
PR Newswire - Thu Jun 19, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the Idenix (Nasdaq:IDIX-Free Report), Achillion Pharmaceuticals (Nasdaq:ACHN-Free Report), Nektar (Nasdaq:NKTR-Free Report), Orexigen (Nasdaq:OREX-Free Report), Celgene (Nasdaq:CELG-Free Report), Alexion (Nasdaq:ALXN-Free Report) and Biogen (Nasdaq:BIIB-Free Report). (full story)
Biotech Stock Roundup: HCV Back in Focus - Idenix, Achillion Soar - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed Jun 18, 9:33AM CDT
It was about hepatitis C cirus (HCV) treatments and companies last week with the Merck-Idenix acquisition announcement grabbing eyeballs. (full story)
Nasdaq stocks posting largest volume increases
AP - Tue Jun 17, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading: (full story)
Nasdaq stocks posting largest percentage increases
AP - Tue Jun 17, 5:03PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading: (full story)
Most active Nasdaq-traded stocks
AP - Tue Jun 17, 5:03PM CDT
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading: (full story)
Critical Alerts For Bank of America, Achillion Pharmaceuticals, Walmart, SunEdison, and Advanced Micro Devices Released By InvestorsObserver
PR Newswire - Tue Jun 17, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for BAC, ACHN, WMT, SUNE, and AMD. (full story)
Achillion Gets Massive Price Target Hike On HCV Drugs
at Investor's Business Daily - Mon Jun 16, 10:18PM CDT
Biotech Achillion Pharmaceuticals (ACHN) got another boost Monday when Maxim Group more than tripled its price target on the stock, sending shares up 21% on the stock market today. After having dinner with company executives, analyst Jason Kolbert... (full story)
Achillion gets price target hike
at Investor's Business Daily - Mon Jun 16, 5:56PM CDT
The biotech company's shares soared 20.9% to 7.82 after Maxim Group more than tripled its price target on Achillion Pharmaceuticals (ACHN) stock. Analyst Jason Kolbert increased his target to 22 from 6 on the potential of hepatitis C drug candidates,... (full story)
Why Fusion-io, Achillion Pharmaceuticals, and Covidien Are Today's 3 Best Stocks
Sean Williams, The Motley Fool - Motley Fool - Mon Jun 16, 4:15PM CDT
Following the first down week for the broad-based S&P 500 in quite some time investors were looking for something positive to start their work week, and a bevy of economic data gave them what they were looking for. Industrial production... (full story)
Why Achillion Pharmaceuticals (ACHN) Is Spiking Today
at The Street - Mon Jun 16, 9:33AM CDT
Achillion Pharmaceuticals (ACHN) is rocketing up after having its price target raised significantly to $22 from $6 by analysts at Maxim. (full story)
3 Stocks That Soared Stupendously This Week
Keith Speights, The Motley Fool - Motley Fool - Sun Jun 15, 8:15AM CDT
How would you like a 40% gain in one week? How about gains of over 120% -- or more than 220%? Shareholders of three health-care stocks don't have to wonder how they'd like those types of returns. They experienced the joy first-hand. One of this... (full story)
This Week in Biotech: Actions Speak Louder Than Words
Sean Williams, The Motley Fool - Motley Fool - Sat Jun 14, 10:20AM CDT
With the SPDR S&P Biotech Index up 39% over the trailing 12-month period , it's evident that investment dollars are willingly flowing into the biotech sector. Keeping that in mind, let's have a look at some of the rulings, studies, and... (full story)
Today's Top Biotech Stocks to Watch: Achillion Pharmaceuticals, Nektar Therapeutics and Progenics Ph
George Budwell, The Motley Fool - Motley Fool - Fri Jun 13, 8:02AM CDT
Let's take a look at today's top stories in biotech and health care. Keep an eye out for Achillion Pharmaceuticals , Nektar Therapeutics and Progenics Pharmaceuticals . Achillion falling back down to Earth Shares of hepatitis C... (full story)
(0)
(0)Alexion Pharmaceuticals Inc. (ALXN) Stock Research Links
Scroll down for more posts ▼